New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
08:02 EDTCTRXCatamaran recent sell-off overdone, says Jefferies
Jefferies views the recent sell-off in shares of Catamaran as overdone. The firm attributes the move to concerns about the company's ability to meet Q1 consensus and win new contracts. Jefferies expects Catamaran shares to bounce back to the mid-$40s soon after the Q1 report and it keeps a Buy rating on the stock.
News For CTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
06:09 EDTCTRXCatamaran reports Q1 adjusted EPS 59c, consensus 57c
Subscribe for More Information
April 29, 2015
15:00 EDTCTRXNotable companies reporting before tomorrow's open
Subscribe for More Information
April 27, 2015
07:13 EDTCTRXUBM Tech to hold a conference
Subscribe for More Information
April 23, 2015
12:08 EDTCTRXLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
April 22, 2015
10:02 EDTCTRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTCTRXCatamaran downgraded to Hold from Buy at Maxim
Maxim downgraded Catamaran to Hold citing the takeover by OptumRx as it does not believe another suitor will emerge with a counter bid.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use